A functional polymorphism in the promoter region of the DRD2 gene has been found to be associated with schizophrenia in Japanese 1,2 and Swedish populations.
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We attempted to replicate these findings in a genetically homogenous Portuguese population using a familybased study design. Analysis of 78 trios revealed evidence for association between the −141 C Ins allele and schizophrenia using the haplotype relative risk (HRR) method ( 2 = 9.30, P = 0.0023). Further examination of this sample using an alternative family-based association analysis method, the transmission disequilibrium test (TDT), of 33 informative matings from the Portuguese trios provided evidence for an allelic association and linkage disequilibrium between the insertion allele and schizophrenia ( 2 = 8.76, P = 0.0031). These consistent results using two alternative family-based association analysis methods replicate the findings of previous reports, and thus further implicate a potential role for the dopamine-2 receptor in the genetic etiology of schizophrenia. Schizophrenia is a chronic and debilitating psychotic disorder of unknown etiology. Twin and family studies consistently demonstrate a genetic component to the disease etiology. Furthermore, the most consistent risk factor for developing the disease is familial relation to a schizophrenic patient. 4 Despite the evidence for a genetic contribution to disease, segregation analyses tend to support multiple gene models of disease etiology or a multifactorial pattern with both genetic and environmental factors contributing to disease susceptibility. 5, 6 Candidate gene association studies are well suited to identify genes of small effect. Traditional population case-control studies are inherently limited by the ability to precisely match the patient and control groups; more sophisticated methods have been developed which diminish the risk of population stratification and ethnic variation. Trio analysis with the haplotype relative risk (HRR) 7, 8 and transmission disequilibrium test (TDT) 9,10 compare transmitted and untransmitted genotypes determined from examining parent/patient trios to provide a more robust association study of candidate genes. The HRR method is a test of association comparing frequency of transmission vs nontransmission of particular markers. TDT analysis, however, evaluates linkage in the presence of association and examines transmissions from heterozygous parents to affected offspring. Therefore, both the HRR and TDT methods can be used to analyze the same data and thus, are alternative and complementary approaches to family-based association.
The therapeutic effect of typical antipsychotic medications, which preferentially antagonize dopamine receptors, has motivated extensive study of dopamine system genes for polymorphic regions that may be associated with schizophrenia. In particular, the clinical potency of the neuroleptic drugs has been shown to be highly correlated with their ability to bind the D2 receptors; 11 thus, the DRD2 receptor gene may be implicated in genetic susceptibility to schizophrenia.
In recent years, some interest was raised when an association was found between a functional polymorphism in the promoter of the DRD2 receptor (−141 C Ins/Del) gene and schizophrenia (P Ͻ 0.001) using a case-control study design in the Japanese population. The initial detection of association with schizophrenia in the Japanese population led to several attempts to replicate the findings. Case-control studies replicated the finding of an association between −141 C Ins allele and schizophrenia within the Swedish population (P Ͻ 0.05) 3 and in a different group of Japanese patients and controls (P Ͻ 0.042). 2 An association with schizophrenia was also reported in a population from the UK but with the −141 C Del allele (P = 0.02). 12 However, studies in Chinese, 13 North American, 14 German 15 and British 16 subjects failed to identify an association. With the exception of Li and colleagues, 13 all of the above studies used a case-control study design. In the family-based study by Li et al, 13 229 trios were examined from the population of SW China. Their study revealed 68 heterozygous parents, yet did not detect evidence for allelic association and linkage disequilibrium (−141 Del: 38; −141 Ins: 30; TDT: 2 = 0.94, P = 0.17). In total, the studies have raised a great deal of inquiry over the potential role of the DRD2 promoter polymorphism in disease susceptibility to schizophrenia but with no clear resolution.
Part of the complexity of the genetic analysis and the ambiguity of genetic findings may lie in the heterogeneity or syndromic nature of the disease, which may in fact represent a collection of genetic subtypes. Studying more homogenous populations has the potential to diminish the heterogeneity of the study population by perhaps examining one, or a few, of many likely subtypes that may have yet to be classified. 17 Therefore, focusing on genetically isolated populations will help to decrease the heterogeneity of the study group. In this study, the DRD2 promoter polymorphism was examined for association with schizophrenia using HRR and TDT analyses with patient/parent trios from the relatively homogeneous Portuguese population. 18 The only other family-based study 13 examined trios in the relatively more heterogeneous Chinese population, which could in turn diminish the capability to detect association.
Seventy-eight schizophrenia probands (48 males, 30 females) and 156 parental controls were genotyped at the DRD2 promoter polymorphism locus. The results of the genotype and allele frequencies are compiled in Table 1 . HRR analysis of the sample revealed evidence for allelic association at the DRD2 promoter polymorphism locus and schizophrenia in the Portuguese population (Table 1-HRR: 2 = 9.30, P = 0.0023). Similar to the findings in the Japanese 1,2 and Swedish populations, 3 the −141 C Del allele was transmitted significantly less often to the probands. The preferential transmission of the −141 C Ins allele was also demon- Table 2 . Because the −141 C Del allele is infrequent, only 33 informative transmissions from heterozygous parents to affected probands were available for the analysis. The study results provided evidence for association and linkage disequilibrium at the DRD2 promoter polymorphism locus (Table 2 -TDT: 2 = 8.76, P = 0.0031). Again, the −141 C Ins allele was preferentially transmitted to the probands.
As detected in the Japanese and Swedish populations, our study examining the more genetically homogenous Portuguese population also detected an association between the −141 C Ins allele and schizophrenia. [1] [2] [3] In the context of a multiple gene or multifactorial etiology of disease, evidence for association may be more easily detected in a more homogeneous population due to the less heterogeneous gene pool. This is one possible explanation for the inconsistent findings between the current findings and those in the previous family-based study of the Chinese population. 13 Previous evidence for association was detected using case-control study designs. However, these studies often meet criticism because population stratification and the ability to appropriately match study groups inherently limit the study. However, our analysis used a family-based study design of parent/patient trios to eliminate some of the problems encountered with ethnic stratification in case-control studies. In total, these findings provide additional independent evidence for association utilizing a more robust methodology.
The TDT study only examines transmissions from heterozygous parents to affected offspring. Therefore, the sample size available for TDT analysis can be lim- ited in the examination of infrequent polymorphisms. Only 33 informative matings were available to provide evidence for association and linkage disequilibrium from the TDT analysis. Therefore, confirmation of such findings by examination of a larger sample size would be beneficial to confirm the findings. Given that the polymorphism is functionally related to gene expression, 1 an association between schizophrenia and DRD2 could represent a functional consequence of the nucleotide insertion/deletion. Correlation between clinical potency of neuroleptic agents and the ability to antagonize the dopamine-2 receptor provides evidence to support that alterations of DRD2 gene expression could effect disease presentation. Post-mortem and neuroimaging studies have demonstrated slightly elevated D2 receptor densities in the striatum of drug-free schizophrenia patients over controls. 19 However, most patients who receive the diagnosis also receive treatment, and the effect of medications to down-regulate the number of receptors limits the availability of subjects for such studies. An alternate hypothesis could be that the −141 C Ins allele demonstrates a higher gene expression and may partially contribute to genetic susceptibility to schizophrenia; however, clarifying the true functional consequences must still be determined. Moreover, the polymorphic marker could be in linkage disequilibrium with another gene variant contributing to the disease susceptibility, rather than the variant itself being the susceptibility factor.
Both case-control and family-based association studies of the DRD2 Ins/Del promoter polymorphism have been inconsistent. However, our findings in a homogenous population support a role of the DRD2 gene in the genetic susceptibility to schizophrenia. Replication of our findings using family-based association studies in larger homogenous populations is warranted to clarify the role of DRD2 as a possible genetic component of schizophrenia.
Methods

Subjects
Patients identified for the study were of Portuguese descent who met DSM-IV criteria for schizophrenia. The trios were collected from the populations of the Azores islands and mainland Portugal. 20 Diagnosis was confirmed using the DIGS (Diagnostic Instrument for Genetics Studies) as described previously. 21 
Genotyping
Genomic DNA was extracted from whole blood according to standard protocols and genotyped via PCR-based restriction analysis. PCR was preformed using primers as detailed by Arnami et al 12 to amplify a 304-bp region. The primers were used to amplify 75 ng DNA in a total volume of 10 l (with 20 mM Tris-HCl, 10 mM KCl, 10 mM (NH 4 ) 2 SO 4 ; 100 g ml Ϫ1 BSA; 2 mM Mg; 0.1% Triton X-100, 250 M dNTPs, 50 ng of each primer, 0.625 units Pfu polymerase). Initial denaturation was carried out for 1 min at 98°C and was followed by 35 cycles of 98°C for 20 s and 74°C for 1 min; final extension was at 72°C for 7 min. The entire PCR product was digested with 5 units of BstNI enzyme and incubated at 37°C. Digestion products were separated on a 2.2% MetaPhor agarose (FMC BioProducts, Rockland ME, USA) gel stained with 0.5 g ml Ϫ1 ethidium bromide and observed under ultraviolet light. Digestion of the 304-bp PCR product yielded two fragments of 160 and 144 bp for the insertion (−141 C Ins) allele whereas the PCR fragment of the deletion (−141 C Del) allele remained undigested (304 bp).
Data analysis
Genotypic and allelic frequencies for the transmitted and untransmitted groups were analyzed for associations using chi-square tests specific for HRR and TDT on 2 × 2 and 2 × 3 contingency tables. The Java TDT/S-TDT Program (Version 1.1) was used to confirm TDT results. 9 The genotypic and allelic frequencies, chisquare statistics, and corresponding P values are all listed in Tables 1 and 2. 
